ChartRow logo
Data provided bySource: Twelve Data
ARWR
$42.99-2.76%
as of close, Nov 17, 2026
☾ AH $42.99 -2.76%
PeersROIVAXSMCYTKIBRXSPYQQQ
Share this page

Arrowhead Pharmaceuticals Inc. total returns by year (including dividends)

As of market close, Nov 17, 2026

Arrowhead Pharmaceuticals Inc. annual returns by year
YearTotal return
2026YTD
-35.2%
2025
+253.1%
2024
-38.6%
2023
-24.6%
2022
-38.8%
2021
-13.6%
2020
+21.0%
2019
+410.7%
2018
+237.5%
2017
+137.4%
2016
-74.8%
2015
-16.7%
2014
-32.0%
2013
+407.0%
2012
-48.9%
2011
-53.2%
2010
+68.9%
2009
-42.4%
2008
-75.7%
2007
-13.7%
2006
+3.1%
2005
-1.6%
2004
+232.3%
2003
+233.3%
2002
-60.0%
2001
-75.8%
2000
+12.7%
1999
-31.3%
1998
+60.0%
1997
-67.9%
1996
-37.6%
1995
+257.1%
1994
-97.5%
1993since Dec 16
-38.9%
Annualized
-10.7%
1994–2026
Average year
+46.6%
32 full years
Best year
+410.7%
2019
Worst year
-97.5%
1994
Positive years
13/32
41% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on ARWR. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Arrowhead Pharmaceuticals Inc.'s average annual return?
Since 1994, Arrowhead Pharmaceuticals Inc. (ARWR) has returned about -10.7% a year (the compound annual growth rate) and an average calendar-year return of 46.6%.
What were Arrowhead Pharmaceuticals Inc.'s best and worst years?
Over 1994–2026, the best year was 2019 (+410.7%) and the worst was 1994 (-97.5%).
How often is Arrowhead Pharmaceuticals Inc. up in a year?
13 of the 32 full years since 1994 were positive — about 41% of the time.

More on Arrowhead Pharmaceuticals Inc.